Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Chinook Therapeutics Inc (NQ: KDNY ) N/A UNCHANGED Last Price Updated: 4:00 PM EDT, Aug 10, 2023 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Headline News about Chinook Therapeutics Inc < Previous 1 2 3 Next > Wednesdays With Wedbush: Analyst Laura Chico On The State Of Biotech December 29, 2021 For most issues in the biotech sector, it was a rough 2021, especially when compared to the gains in the S&P 500 index, Wedbush's Laura Chi... Via Benzinga Week In Review: BeiGene Raises $3.5 Billion In Shanghai STAR Board IPO December 04, 2021 Beijing's BeiGene announced its Shanghai STAR Exchange IPO will raise $3.5 billion in gross proceeds for the company, more than the predictions of $3 billion. It is the third listing for the company,... Via Talk Markets Topics Initial Public Offering Exposures Securities Market 76 Biggest Movers From Yesterday November 11, 2021 Gainers Expensify, Inc. (NASDAQ: EXFY) jumped 52.1% to settle at $41.06 on Wednesday after the company priced its IPO at $27 per share. RenovoRx, Inc. (NASDAQ: RNXT) shares... Via Benzinga Topics Initial Public Offering Exposures Securities Market The Daily Biotech Pulse: Double Dose Of Positive Tidings For Merck, Alkermes Slips On Partial Termination Of J&J Licensing Deal, Amgen Migraine Drug Data November 09, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Merck Gets Antitrust Nod For Acceleron Deal In Germany, Austria, Announces... Via Benzinga 12 Health Care Stocks Moving In Friday's Intraday Session November 05, 2021 Gainers Chinook Therapeutics (NASDAQ:KDNY) shares increased by 28.75% to $15.76 during Friday's regular session. Trading volume for this security as of 12:30 EST is 1.... Via Benzinga 92 Biggest Movers From Friday November 08, 2021 Gainers Mainz Biomed B.V. (NASDAQ: MYNZ) shares jumped 99.8% to close at $9.99 on Friday. Mainz Biomed priced its initial public offering of 2 million ordinary shares at $5, the... Via Benzinga 64 Stocks Moving In Friday's Mid-Day Session November 05, 2021 Gainers Mainz Biomed B.V. (NASDAQ: MYNZ) shares climbed 198.4% to $14.92. Mainz Biomed priced its initial public offering of 2 million ordinary shares at $5, the middle of the... Via Benzinga The Past Week's Notable Insider Buys Include AppLovin, Cricut, Biotechs, And More August 21, 2021 With earnings-reporting season all but over, many insiders are free once more to buy or sell shares. Here are a few of the most noteworthy insider purchases that were reported in the past week. Via Talk Markets The Daily Biotech Pulse: Merck's Oral COVID-19 Pill Authorized In UK, Novartis Cashes Out Of Roche, Chimerix Plunges On Data, Evotec IPO November 04, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Merck's Oral Antiviral COVID-19 Pill Authorized In UK Merck &... Via Benzinga Exposures COVID-19 The Past Week's Notable Insider Buys Included AppLovin, Cricut, Biotechs And More August 21, 2021 Insider buying can be an encouraging signal for potential investors, especially when markets are near all-time highs. Some insiders were making return trips to the buy window... Via Benzinga The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline October 31, 2021 Biotech stocks rose a third week running in the week ending Oct. 29 amid positive reaction to earnings. Big pharma earnings were mostly better than expected. Merck & Co, Inc... Via Benzinga Aurinia Answers 'What's Next?' And Investors Punish AUPH Stock August 17, 2021 Aurinia snagged a pair of early-stage drugs for roughly $6.8 million on Tuesday, but AUPH stock tumbled into a key moving average. Via Investor's Business Daily 12 Health Care Stocks Moving In Friday's Intraday Session June 18, 2021 Gainers Geron (NASDAQ:GERN) shares increased by 53.19% to $2.16 during Friday's regular session. As of 12:33 EST, Geron's stock is trading at a volume of 179.2... Via Benzinga 32 Stocks Moving In Friday's Mid-Day Session June 18, 2021 Gainers CAI International, Inc. (NYSE: CAI) shares jumped 46.4% to $55.86 after the company agreed to a $1.1 billion takeover by Mitsubishi HC Capital Inc. Sykes Enterprises,... Via Benzinga Chinook Therapeutics' BION-1301 Shows Reduction In 24-Hour Proteinuria In Nephropathy Trial June 08, 2021 Chinook Therapeutics Inc (NASDAQ: KDNY) has announced interim data from the ongoing Phase 1/2 study of BION-1301 in patients with IgA Nephropathy (IgAN). The... Via Benzinga The Daily Biotech Pulse: Hookipa, PDS Biotech Report Positive Data, Ironwood CFO To Depart, Decision Day For Vertex June 08, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 7) Agios Pharmaceuticals, Inc... Via Benzinga 12 Health Care Stocks Moving In Friday's Intraday Session April 16, 2021 Gainers BioCryst Pharmaceuticals (NASDAQ:BCRX) shares rose 11.13% to $11.32 during Friday's regular session. As of 08:06 EST, this security is trading at a volume of 8... Via Benzinga The Week Ahead In Biotech: Biogen, Alexion And Vertex FDA Decisions, Multiple Conference Presentations On The Deck June 07, 2021 Biopharma stocks advanced in the truncated week ended June 4 amid the broader market strength. The American Society for Clinical Oncology meeting got underway during the week,... Via Benzinga Exposures Product Safety The Week Ahead In Biotech (April 11-17): Avenue Therapeutics FDA Decision and Conference Presentations In The Spotlight April 10, 2021 Contrary to the strength in the broader market, biotech stocks ended the week ending April 9 lower. The weakness partly reflected a preference for risky bets at the expense of... Via Benzinga Exposures Product Safety The Daily Biotech Pulse: Merck Shelves 2 COVID-19 Studies, Bristol-Myers Squibb Gets European Regulatory Nod, InspireMD's Reverse Split April 15, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 14) 10x Genomics, Inc. (NASDAQ... Via Benzinga Exposures COVID-19 < Previous 1 2 3 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.